Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.

Authors :: Rovelli A
Corti P
Beretta C
Bovo G
Conter V
Mieli-Vergani G
Source :: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2007 Nov; Vol. 45 (5), pp. 596-9.
Publication Year :: 2007

Subjects :: Alemtuzumab
Anemia, Hemolytic, Autoimmune diagnosis
Antibodies, Monoclonal administration & dosage
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antibodies, Neoplasm adverse effects
Antineoplastic Agents adverse effects
Azathioprine administration & dosage
Biopsy
Celiac Disease complications
Celiac Disease diagnosis
Celiac Disease diet therapy
Child, Preschool
Coombs Test
Cyclosporine administration & dosage
Diagnosis, Differential
Follow-Up Studies
Glucocorticoids administration & dosage
Hepatitis diagnosis
Humans
Immunologic Factors administration & dosage
Immunosuppressive Agents administration & dosage
Infant
Liver drug effects
Liver pathology
Liver Function Tests
Male
Methylprednisolone administration & dosage
Mycophenolic Acid administration & dosage
Mycophenolic Acid analogs & derivatives
Prednisone administration & dosage
Rare Diseases
Remission Induction methods
Rituximab
Anemia, Hemolytic, Autoimmune complications
Antibodies, Monoclonal therapeutic use
Antibodies, Neoplasm therapeutic use
Antineoplastic Agents therapeutic use
Hepatitis complications
Hepatitis drug therapy

Full Text Access

Tools